{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:10:24Z","timestamp":1760299824879},"reference-count":22,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej17-0431","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T22:15:32Z","timestamp":1520288132000},"page":"521-526","source":"Crossref","is-referenced-by-count":10,"title":["Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps"],"prefix":"10.1507","volume":"65","author":[{"given":"Ayumi","family":"Imbe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuiko","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Shishikura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Imbe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungo","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Imagawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hanafusa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka 569-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Katzberg HD (2015) Neurogenic muscle cramps. J Neurol 262: 1814\u20131821.","DOI":"10.1007\/s00415-015-7659-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Nakanishi H, Kurosaki M, Tsuchiya K, Nakakuki N, Takada H, et al. (2015) L-carnitine reduces muscle cramps in patients with cirrhosis. Clin Gastroenterol Hepatol 13: 1540\u20131543.","DOI":"10.1016\/j.cgh.2014.12.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, et al. (1998) Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 32: 258\u2013264.","DOI":"10.1053\/ajkd.1998.v32.pm9708610"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Katzberg H, Kokokyi S, Halpern E, Lovblom E, Barnett C, et al. (2014) Prevalence of muscle cramps in patients with diabetes. Diabetes Care 37: e17\u2013e18.","DOI":"10.2337\/dc13-1163"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Davies M, Brophy S, Williams R, Taylor A (2006) The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 29: 1518\u20131522.","DOI":"10.2337\/dc05-2228"},{"key":"6","unstructured":"6 Fukuhara S, Suzukamo Y (2004) Manual of SF-36v2 Japanese version. Institute for Health Outcomes & Process Evaluation research, Kyoto (In Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tapp RJ, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, et al. (2006) Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Diabetes Res Clin Pract 74: 154\u2013161.","DOI":"10.1016\/j.diabres.2006.03.012"},{"key":"8","unstructured":"8 Kamarul Imran M, Ismail AA, Naing L, Wan Mohamad WB (2010) Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J 51: 157\u2013162."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51: 1045\u20131053.","DOI":"10.1016\/S0895-4356(98)00096-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 51: 1037\u20131044.","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"11","unstructured":"11 Dambrova M, Liepinsh E (2015) Risks and benefits of carnitine supplementation in diabetes. Exp Clin Endocrinol Diabetes 123: 95\u2013100."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Poorabbas A, Fallah F, Bagdadchi J, Mahdavi R, Aliasgarzadeh A, et al. (2007) Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 61: 892\u2013895.","DOI":"10.1038\/sj.ejcn.1602594"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Li S, Li Q, Li Y, Li L, Tian H, et al. (2015) Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. PLoS One 10: e0119479.","DOI":"10.1371\/journal.pone.0119479"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Chatrath H, Liangpunsakul S, Ghabril M, Otte J, Chalasani N, et al. (2012) Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med 125: 1019\u20131025.","DOI":"10.1016\/j.amjmed.2012.03.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Benbow SJ, Wallymahmed ME, MacFarlane IA (1998) Diabetic peripheral neuropathy and quality of life. QJM 91: 733\u2013737.","DOI":"10.1093\/qjmed\/91.11.733"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Cocito D, Paolasso I, Pazzaglia C, Tavella A, Poglio F, et al. (2006) Pain affects the quality of life of neuropathic patients. Neurol Sci 27: 155\u2013160.","DOI":"10.1007\/s10072-006-0660-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Dermanovic Dobrota V, Hrabac P, Skegro D, Smiljanic R, Dobrota S (2014) The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes 12: 171.","DOI":"10.1186\/s12955-014-0171-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, et al. (2006) The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 49: 2272\u20132280.","DOI":"10.1007\/s00125-006-0380-7"},{"key":"19","unstructured":"19 Brown GC (1999) Vision and quality-of-life. Trans Am Ophthalmol Soc 97: 473\u2013511."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31: 247\u2013263.","DOI":"10.1097\/00005650-199303000-00006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Keller SD, Ware JE Jr, Bentler PM, Aaronson NK, Alonso J, et al. (1998) Use of structural equation modeling to test the construct validity of the SF-36 health survey in ten countries: results from the IQOLA Project. J Clin Epidemiol 51: 1179\u20131188.","DOI":"10.1016\/S0895-4356(98)00110-3"},{"key":"22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","volume":"109","author":"R Sabatowski","year":"2004","unstructured":"22 Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, et al. (2004) Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109: 26\u201335.","journal-title":"Pain","ISSN":"http:\/\/id.crossref.org\/issn\/0304-3959","issn-type":"print"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0431\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T07:54:48Z","timestamp":1660550088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0431\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0431","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}